CompletedNot Applicable

Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)

Sweden620 participantsStarted 2011-10-31

Plain-language summary

This observational study of a national cohort of 600 Swedish PSC patients include yearly MR/MRCP, biobanking of serum, plasma and blood, followup clinical data (interventions, symptoms, labs, colonoscopy). The aim is to collect a well characterized cohort of PSC patients and provide future possibilities to evaluate biomarkers for prognosis and early cancer detection.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of PSC by MR/MRCP * Life expectancy \>1 year * Informed consent Exclusion Criteria: * Liver transplantation or on the waiting list * Secondry SC * Diagnosis of CCA

What they're measuring

cholangiocarcinoma

Timeframe: 10 yrs f-up

liver transplatation

Timeframe: 10 yrs f-up

death

Timeframe: 10 yrs f-up

Trial details

NCT IDNCT03041662

SponsorKarolinska University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-10-31

View on ClinicalTrials.gov More Primary Sclerosing Cholangitis trials